title: Update on depression and age-related macular degeneration.
abstract: OBJECTIVE
  This review updates the literature on depression in age-related macular degeneration (AMD). Treatment for AMD has been revolutionized since the 2004 review of depression and AMD. New data describing the prevalence of depression in AMD, as well as novel interventions for managing depression in AMD, are discussed.
  
  
  RESULTS
  Depression continues to be prevalent in AMD and new information is available on the pathways by which impaired vision leads to depression. Strategies for the treatment of depression in patients with impaired vision have evolved.
  
  
  CONCLUSIONS
  AMD is still a major risk factor for depression and people with activity restriction due to vision loss are at greatest risk. An integrated approach to depression management in older adults with impaired vision may be the best course of action.
authors: Department of Psychiatry and Human Behavior, Jefferson Medical College, Philadelphia, PA 19107, USA. Robin.Casten@jefferson.edu
authors: Robin J
authors: RJ
authors: Casten
authors: Barry W
authors: BW
authors: Rovner
mesh_terms: D000368:Aged; D001766:Blindness / Q000503:physiopathology; D003866:Depressive Disorder / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D006801:Humans; D008268:Macular Degeneration / Q000453:epidemiology / Q000503:physiopathology* / Q000628:therapy; D015995:Prevalence; D012307:Risk Factors; D015354:Vision, Low / Q000503:physiopathology